We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Revco Parent Acquires Kendro for $320 Million

By HospiMedica staff writers
Posted on 27 Jul 2001
SPX Corp., the parent of Revco, Jewett and other lab equipment brands (Muskegon, MI, USA), has acquired Kendro Laboratory Products, L.P. More...
(Newtown, CT, USA) for US$320 million. Kendro's products include centrifuges, incubators, ovens, freezers, and clean-air equipment. Many of its products serve the bioprocessing and drug-discovery segments of the life sciences market, while others serve the clinical laboratory market.

Kendro has annual revenues in excess of US$200 million. Its products are marketed under the Heraeus, Sorvall, and Carr brand names. The company will become part of Revco Technologies, SPX's life sciences business based in Asheville, North Carolina (USA). The combined company will derive more than 50% of its revenues from international markets. Revco is a leading manufacturer of controlled-temperature equipment for the life sciences and clinical laboratory markets. SPX is a global provider of technical products, systems, and services.


Related Links:
Revco
SPX
Kendro

New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
New
Automated Clinical Chemistry Analyzer
Envoy 500+
New
Food Allergy Screening ELISA Kit
Allerquant 14G B ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The device contains specific antibodies that capture the primary biomarker of pancreatic cancer. The binding of these antibodies alters the distribution of electrical charges on the electrode surface. The sensor then translates this variation into a measurable capacitance signal (photo courtesy of Gabriella Soares / IFSC-USP)

Rapid Biosensor Detects Pancreatic Cancer Biomarker for Early Detection

Pancreatic cancer is frequently identified only after it has progressed because early disease is typically asymptomatic, and survival remains extremely poor once advanced. Conventional laboratory assays... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.